Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone

Những quyển sách tương tự

• Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
  Bằng: Wen, Miaomiao, et al.
  Được phát hành: (2018)
• Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
  Bằng: Attili, Ilaria, et al.
  Được phát hành: (2020)
• Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients
  Bằng: Yan, Han, et al.
  Được phát hành: (2015)
• P20. The role of statins in patients with advanced NSCLC harboring KRAS mutation treated with EGFR-TKIs
  Bằng: Fiala, Ondrej, et al.
  Được phát hành: (2014)
• Traditional Chinese Medicine Prolongs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations
  Bằng: Tang, Mo, et al.
  Được phát hành: (2019)